Winslow Evans & Crocker’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Winslow Evans & Crocker’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,656	Closed	-$4K	–	1176
2019 Q3	$4K	Buy	+3,656	New	+$2.04K	﹤0.01%	1053

Winslow Evans & Crocker's CELGZ Position: Q4 2019 in Review

Winslow Evans & Crocker sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 3,656 shares — an estimated $4K sold.

Winslow Evans & Crocker first reported a position in CELGZ in Q3 2019 and held it in 1 quarter. The position peaked at $4K in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

Winslow Evans & Crocker reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
Winslow Evans & Crocker sold 3,656 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $4K.
Winslow Evans & Crocker first reported a position in Celgene Corporation Contingent Value Rights in Q3 2019 and held it in 1 quarter.
Winslow Evans & Crocker's Celgene Corporation Contingent Value Rights position peaked at $4K in Q3 2019.
0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Winslow Evans & Crocker's 13F filing for Q4 2019, filed 14 Jan 2020.